Shepherd S F, A'Hern R P, Pinkerton C R
Department of Clinical Oncology, Royal Marsden Hospital, Surrey, UK.
Br J Cancer. 1995 Sep;72(3):752-6. doi: 10.1038/bjc.1995.405.
This study presents a retrospective review of chest radiography in children with Murphy stage III T-cell lymphoblastic lymphoma. All received a standard leukaemia-based protocol with intensive induction, consolidation and continuing chemotherapy. Neither initial thoracic disease bulk nor the presence of a pleural effusion predicted outcome. However a significant difference was found when the 50 patients in whom the chest radiograph returned to normal within 60 days of commencing treatment were compared with the 18 patients with persistent mediastinal abnormalities, for both event-free [hazard ratio < or = 60 days to > 60 days (HR) 3.55 (95% CI 1.33-9.48); P = 0.007] and overall survival [HR 2.95 (95% CI 1.07-8.18); P = 0.03]. It appears that this relatively simple estimate of chemosensitivity may identify a group of particularly good-risk patients in whom drugs associated with late morbidity such as anthracyclines may be reduced and conversely a higher risk group in whom further intensification of treatment would be justified.
本研究对墨菲Ⅲ期T细胞淋巴母细胞淋巴瘤患儿的胸部X线摄影进行了回顾性分析。所有患儿均接受了基于白血病的标准化方案,包括强化诱导、巩固和持续化疗。初始胸部疾病体积和胸腔积液的存在均不能预测预后。然而,将开始治疗后60天内胸部X线片恢复正常的50例患者与纵隔持续异常的18例患者进行比较时,发现无事件生存率[风险比<或=60天至>60天(HR)3.55(95%CI 1.33-9.48);P=0.007]和总生存率[HR 2.95(95%CI 1.07-8.18);P=0.03]均存在显著差异。看来,这种相对简单的化疗敏感性评估可能识别出一组风险特别低的患者,对于这些患者,可以减少使用如蒽环类药物等与晚期发病率相关的药物;相反,也能识别出一组风险较高的患者,对于这些患者,进一步强化治疗是合理的。